<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27611588</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-4311</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Immunological investigations</Title><ISOAbbreviation>Immunol Invest</ISOAbbreviation></Journal><ArticleTitle>HLA Class II with Lupus Nephritis in Moroccan Patients.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>9</EndPage><MedlinePgn>1-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/08820139.2016.1208218</ELocationID><Abstract><AbstractText>Lupus nephritis (LN) is a disease with a poor prognosis. The association between LN and the Human leukocyte antigen (HLA) genes has never been studied on a Moroccan population. The aim of this work was to evaluate the distribution of the HLA class II alleles in patients with LN and to determine susceptible and protective HLA alleles/haplotypes in LN. The association between these alleles, disease severity of LN, and age at onset were also investigated. Seventy-five patients with LN were compared with 169 healthy unrelated controls. HLA class II alleles typing was performed by polymerase chain reaction-sequence-specific primers (PCR-SSP). A significant increase of HLA-DRB1*15 allele frequency (p = 0.001) and a significant decrease of the HLA-DRB1*04 allele (p = 0.04) were observed in LN patients. The frequency of HLA-DRB1*15-DQB1*06 haplotype (p = 0.003) was increased in the patients while that of HLA-DRB1*04-DQB1*03 (p = 0.027) was decreased. A significant increase of HLA-DRB1*15 allele frequency (p = 0.0001) and HLA-DRB1*15-DQB1*06 haplotype (p = 0.002) was observed in patients with class IV LN. In the Moroccan population we demonstrated the positive association of HLA class II alleles and haplotypes with LN and with a severe form of nephritis. HLA-DRB1*15 allele does not determine the age of disease onset in LN.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhallil</LastName><ForeName>Ouahiba</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>a UPR of Immunology, Faculty of Medicine and Pharmacy , University Mohamed V , Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahimi</LastName><ForeName>Aicha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>b Department of Nephrology , Dialysis and Kidney Transplantation , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouadghiri</LastName><ForeName>Sanae</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>c Department of Immunology and Transfusion , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouzeddoun</LastName><ForeName>Naima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>b Department of Nephrology , Dialysis and Kidney Transplantation , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benseffaj</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>a UPR of Immunology, Faculty of Medicine and Pharmacy , University Mohamed V , Rabat , Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Immunology and Transfusion , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayahia</LastName><ForeName>Rabia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>b Department of Nephrology , Dialysis and Kidney Transplantation , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Essakalli</LastName><ForeName>Malika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>a UPR of Immunology, Faculty of Medicine and Pharmacy , University Mohamed V , Rabat , Morocco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>c Department of Immunology and Transfusion , CHU Ibn Sina, Rabat , Morocco.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immunol Invest</MedlineTA><NlmUniqueID>8504629</NlmUniqueID><ISSNLinking>0882-0139</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C527195">HLA-DRB1*04 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507799">HLA-DRB1*15 antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009018" MajorTopicYN="N">Morocco</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Human leukocyte antigen</Keyword><Keyword MajorTopicYN="N">Moroccan population</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27611588</ArticleId><ArticleId IdType="doi">10.1080/08820139.2016.1208218</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>